Introduction
============

Case-control and cohort studies of middle-aged populations have consistently demonstrated U- (or J-) shaped relationships between alcohol consumption and the incidence of major vascular diseases (in particular coronary heart disease \[CHD\]) ([@b1]; [@b7]; [@b51]). Typically, CHD risk among middle-aged people who drink light-to-moderate amounts of alcohol (usually defined as around 20 g to 30 g of alcohol per day) is found to be between 20% and 30% lower than for those who do not drink ([@b7]). Similar findings, but perhaps weaker evidence of benefit, have been reported for stroke ([@b51]). In contrast, the harmful effects of heavy drinking are equally well documented. People who drink excessively (usually defined as at least 40 g of alcohol per day) generally have higher rates of CHD and stroke than people who drink moderately, though often at a level only either comparable with, or slightly in excess of, the disease rates experienced by nondrinkers. While most of these studies have been of middle-aged men, several large studies have also demonstrated that these relations exist in middle-aged women ([@b19]; [@b64]).

So what could account for a U- or J-shaped relationship between alcohol consumption and the risk of CHD and stroke? Is the association between light-to-moderate drinking and lower vascular risk causal, or a consequence of unknown biases in observational studies? Furthermore, if moderate alcohol intake (as opposed to abstinence) does reduce vascular risk, why is heavy drinking associated with increased vascular risk? In order to address these questions, it is important to appreciate several complicating issues (summarized in [Table 1](#tbl1){ref-type="table"}). First, the amount of alcohol consumed is only one component of "alcohol exposure". Both the type of drink consumed and the pattern of drinking may have important modifying influences on vascular risk independently of the amount. Thus, the apparent vascular benefit of light-to-moderate drinking (as well as the harm associated with heavy drinking) could be explained as much by differences in the *way that alcohol is consumed* in different drinking categories, as it is to differences in the *amount of alcohol consumed*. Second, alcohol consumption is an exposure that is difficult to measure accurately and therefore can be easily misclassified. Biases in the reporting of alcohol consumption may alter the magnitude and, if systematic, even the direction of apparent risk-relationships. This may be particularly relevant for case-control studies, in which cases are asked to recall what their drinking habits were prior to their heart attack or stroke. Perhaps more importantly, people who regularly drink light or moderate amounts of alcohol also tend to exhibit other characteristics that are particularly beneficial to health. For example, they may be more likely to take regular physical activity. It is possible that these other characteristics are reducing vascular risk, rather than alcohol. Alcohol consumption patterns also tend to change over time, either due to the presence of disease (so called "reverse-causality") or sometimes as a natural consequence of aging. Single assessments of alcohol consumption recorded at the beginning of a cohort study may therefore be unable to accurately reflect true "average" exposures to alcohol *during* a study. In addition, if the non-drinking category contained a significant proportion of people who had given up alcohol because of ill health, their disease risks would not be truly reflective of the true risks associated with non-drinking. Finally, there may be bias in the literature, both in the tendency for authors and journals to publish "favorable" results (publication bias), and the common tendency for authors to interpret their results only in the context of their prior beliefs. Thus, for several reasons, there is some doubt when interpreting the alcohol---vascular disease risk relationship as entirely causal. Nonetheless, alcohol is known to have some favorable biological effects that would be expected to reduce vascular risk. In particular, it increases high density lipoprotein-cholesterol (HDL-C) ([@b54]), a protective risk factor for CHD ([@b55]), and possibly also for (non-hemorrhagic) stroke ([@b35]; [@b62]; [@b73]). It also has a modest beneficial effect on thrombotic factors, particularly fibrinogen. On the other hand, it increases blood pressure, which might offset (to some degree at least) the expected benefits on blood lipids.

###### 

Potential sources of bias in epidemiological studies of the relationship between alcohol consumption and the risk of vascular disease

  Source of bias                                                Description
  ------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Confounding by type of drink or pattern of drinking           If either the type of drink consumed (eg, beer, wine, or spirits) or the pattern of drinking (eg, with/without meals, regular/episodic) have effects on risk independently of amount consumed (and if these characteristics vary with amount consumed), then these factors will confound the observed relationship between amount of alcohol consumed and risk.
  Confounding by socio-economic and lifestyle characteristics   Differences in socio-economic and lifestyle characteristics between different drinking groups causes confounding of the true relationship between alcohol consumption and vascular risk. Even if attempts are made to adjust for these characteristics, some residual confounding will still generally occur.
  Choice of reference group                                     Use of nondrinkers as the reference group with which to compare different levels of active drinking could lead to misleading results if the group includes ex-drinkers, particularly those who gave up because of ill health (see also "reverse causality bias").
  Reverse causality bias                                        A previous diagnosis of vascular disease might cause a change (typically a reduction) in an individual\'s alcohol consumption, leading to the subsequent high incidence rates among such people being incorrectly attributed to the new level of drinking.
  Recall error/misclassification                                Errors in the reporting of alcohol consumption can alter the magnitude and even direction of true risk-relationships with alcohol intake. For instance, cases in case-control studies might systematically under-report their previous alcohol intake.
  Within-person variation                                       In prospective cohort studies, variations in an individual\'s alcohol intake over time can distort the risk-relationship between *average* alcohol intake during the study and risk, when baseline measures of alcohol intake are used in analyses.
  Study design/publication bias                                 Case-control studies may be more susceptible to biases in exposure recall than cohort studies and also have the difficultly of finding an appropriate control group. Alcohol-disease association studies may also be more likely to be submitted for publication (and accepted) if it shows a striking result, asopposed to small studies with less striking results.

The purpose of this review is to consider to what degree these potential biases and potential causal mechanisms might credibly account for the shape and magnitude of the relationships between alcohol consumption and the risks of CHD and stroke. Each of the major potential sources of bias are reviewed and, where possible, the effects of taking them into account illustrated using examples from published studies. The most likely causal mechanisms and their expected effects are also reviewed using evidence from large overviews of epidemiological studies.

Alcohol and coronary heart disease
==================================

Since the early 1970s, many observational epidemiological studies have reported a cardioprotective effect of moderate amounts of alcohol. In a review of five case-control studies, seven prospective studies, two international comparisons, and one time-trend report published in 1984, it was concluded that moderate alcohol intake was associated with lower risks of CHD mortality, but that heavy drinking was associated with higher mortality compared with nondrinkers ([@b37]). In 2000, a meta-analysis of 28 prospective studies which investigated the relationship between alcohol and CHD risk and which, based on factors relating to study design, data collection methods and data analysis strategy, were deemed to be of a "high quality", estimated that 20 g of alcohol a day (1--2 standard drinks) was associated with a 20% (95% confidence index \[CI\] 17% to 22%) reduction in the relative risk of CHD ([@b7]). This protective effect was found to persist up to a consumption as high as 72 g/day and only became significantly harmful after 89 g/day (approximately 7 standard drinks a day); see [Figure 1](#fig1){ref-type="fig"}.

![Impact of choice of reference category on the relationship between alcohol intake and the risk of coronary heart disease.\
The solid line shows data from 28 cohort studies (adapted and reproduced with permission from Figure 2 of Corrao et al. 2004. A meta-analysis of alcohol consumption and the risk of 15 diseases. *Prev Med*, 38: 613-19) and shows the estimated risk-relationship when nondrinkers are used as the reference category. The dashed line shows the same curve with light drinkers (1 g/day) as the reference category. The distances a and b represent the extent that use of nondrinkers as the reference category might lead to overestimation of the benefits of moderate alcohol consumption and overestimation of the level at which alcohol consumption may become cardiotoxic.](vhrm0203-239-f1){#fig1}

Amount, type, or drinking pattern?
----------------------------------

Total alcohol consumption, though the most widely used and probably the most informative, provides only one method of looking at an individual\'s overall "alcohol exposure". For many years, it has been suggested that both the type of drink consumed (eg, beer, wine, or spirits) as well as the pattern of drinking (eg, daily with meals, weekends only) may have contributing effects on CHD risk that are separate from those of the total amount of alcohol consumed. Wine, for instance, has been widely claimed to contain substances other than ethanol that have cardioprotective effects. In fact, it has often been suggested that despite high smoking rates and typically high fat diets, the French experience low CHD rates because of their high levels of wine intake ([@b50]). Numerous substances in wine related to platelet aggregation, low-density lipoprotein (LDL) oxidation inhibition, vasodilating effects and effects on the endothelium have been proposed as potentially beneficial ([@b18]; [@b46]; [@b16]; [@b24]), but none have so far been confirmed to be causally important. In populations where beer, wine, and spirits are all commonly consumed, several studies have indeed found wine drinkers to be at lower CHD risk than beer or spirit drinkers ([@b72]; [@b21]; [@b63]). However, when making these comparisons, it is important to take account of the very different socioeconomic characteristics these groups tend to have. In a meta-analysis of 26 observational studies, it was estimated that wine and beer reduced the risk of vascular disease by 32% and 22% respectively ([@b9]). However, because no meaningful relationship could be found between different amounts of beer intake and vascular risk, the results were difficult to interpret. In another meta-analysis of the effects of beer, wine, and spirits on CHD risk, the authors concluded that the major portion of the benefit associated with alcohol consumption was due to ethanol itself, rather than any other components of each type of drink ([@b53]). This view is indirectly supported by the observation that in the mainly beer-drinking populations of Bavaria (Germany) and the Czech Republic, the protective effects of alcohol are similar to those observed in the mainly wine drinking Mediterranean countries ([@b29]; [@b4]).

In addition to the type of alcohol consumed, the role that pattern of drinking may play in determining CHD risk has also generated much interest. In particular, drinking with meals (compared with drinking without meals) has been found to be associated with a beneficial effect on CHD risk and other outcomes ([@b66], [@b65]), possibly due to effects on blood pressure ([@b17]), thrombotic factors ([@b22]) or lipids ([@b67]). In contrast, irregular heavy drinking (binge drinking) has been shown to be associated with increased CHD risk for many years. Indeed, it has been debated whether binge drinking may have been responsible for the sharp rise in national cardiovascular disease rates observed in Russia during the early 1990s (following a previously successful anti-alcohol campaign between 1984 and 1987) ([@b34]; [@b3]; [@b41]). Several case-control and prospective studies have found that for a given level of total alcohol consumption, people who drink in binges rather than regularly tend to have higher rates of CHD ([@b28]; [@b40]; [@b49]; [@b44]) in addition to higher rates of other forms of cardiovascular disease (including sudden cardiac death) ([@b69]; [@b27]; [@b75]). In a review article published in 1999, the importance of considering drinking pattern when considering the effects of alcohol on cardiovascular disease risk was highlighted ([@b48]). The authors concluded that without proper understanding of the risks associated with different drinking patterns, public health advice regarding alcohol consumption would be limited in its scope and potentially flawed in its impact.

Choice of reference category
----------------------------

Most epidemiological studies of the effects of alcohol on CHD risk use nondrinkers as the reference category against which the effects of different levels of drinking are compared. However, if this group contains people who used to drink alcohol but have given up, any true benefits of alcohol consumption on risk are likely to become exaggerated. This is because ex-drinkers tend to exhibit several characteristics likely to increase their morbidity and mortality. In the British Regional Heart Study, ex-drinkers were found to have the highest prevalence of diagnosed CHD, diabetes, and bronchitis as well as the highest use of medication ([@b68]). A high proportion smoked cigarettes, were of manual social class, were unmarried, and had measured hypertension and obesity. Similar characteristics among ex-drinkers have also been observed elsewhere ([@b14]). While most epidemiological studies would tend to make attempts to take account of differences in the prevalence of risk factors and pre-existing disease in the different drinking groups (for instance, by excluding patients with known prior disease and making statistical adjustments for differences in the prevalence of risk factors) such corrections might only partially remove these effects. The proportion of nondrinkers comprising of ex-drinkers is also likely to vary considerably by population studied, and though for some countries this proportion may be small, for others the nondrinking category could become significantly contaminated by ex-drinkers (particular for older study populations). The overall bias this could introduce has been suggested by some to be small ([@b36]), nonetheless it is clearly desirable for epidemiological studies of the effects of alcohol on health to be able to separate ex-drinkers from lifelong abstainers so as to examine these potential effects. In an updated 23-year report from the British Doctor\'s Study, for instance, ex-drinkers were separated from never drinkers. The study found that 2--3 units (16--24 g) of alcohol a day was associated with a reduction in CHD death of 28% (95% CI 12% to 42%) ([@b10]). However, it has been argued by some that lifelong abstainers should not provide the reference category for estimation of the health effects of alcohol consumption either ([@b71]; [@b14]). In countries where alcohol consumption is socially normal, lifelong abstainers often form a small and self-selected group and have been suggested to possess characteristics that could increase their risk of mortality, particularly from non-cardiovascular causes. Given the concerns regarding the suitability of nondrinkers (with or without first separating out ex-drinkers) to act as a valid reference group, a "low" active drinking exposure group (for instance people who drink only on special occasions) may provide a larger more reliable reference category on which to base risk comparisons. To illustrate the impact such a change in reference category could have, [Figure 1](#fig1){ref-type="fig"} shows the relationship between alcohol intake and CHD risk estimated by a meta-analysis of 28 cohort studies ([@b6]), and shows that if people who drink 1 g of alcohol a day are used as the reference category instead of nondrinkers, both the estimated benefits of moderate alcohol intake on CHD risk and the level at which alcohol causes notable harm are substantially reduced. While several studies now routinely use low active drinking groups as the reference category, many still use nondrinkers (often without first removing ex-drinkers) as their comparison group.

Reverse causality bias
----------------------

Part of the concern over the use of nondrinkers as the reference category for alcohol--CHD association studies lies in the possibility that some people may give up alcohol because of ill health prior to enrolment into a study. If this ill health is CHD, reverse causality bias occurs, ie, pre-existing CHD causes a change in alcohol intake (rather than vice-versa), with the consequent risk that the high CHD incidence observed in this group is incorrectly attributed to their new level of drinking. Several studies have shown that after exclusion of people with prior CHD, the apparent benefits of light-to-moderate drinking (compared with nondrinking) are reduced ([@b58]; [@b33]; [@b13]). However, in a deductive meta-analysis published in 1993 ([@b36]), this "sick quitter" hypothesis was refuted on the basis of contrary evidence from several very large cohort studies, including the Nurse\'s Health Study ([@b59]), the American Cancer Society ([@b5]), the Health Professionals Follow-up Study ([@b52]) and the Kaiser Permanente Study ([@b31]), all of which found the association between alcohol and CHD to be essentially unaffected by exclusion of ex-drinkers and people with chronic illness (though in the latter study it was noted that differences in total mortality between nondrinkers and drinkers may well be exaggerated by the presence of people with prior chronic illnesses in the nondrinking group; \[[@b31]\]).

Within-person variation in alcohol consumption
----------------------------------------------

Almost all prospective studies of alcohol--CHD relationships use single baseline assessments of alcohol intake (usually ascertained by interview or questionnaire) in analyses. However, characterization of an individual\'s "exposure to alcohol" (irrespective of how this is actually defined) based on a single assessment may not accurately reflect that person\'s true long-term "usual" or "average" alcohol exposure throughout the duration of the study. Recall bias in alcohol intake, short-term deviations from a person\'s "normal" drinking habit at baseline, and long-term true changes in an individual\'s drinking habit (referred to as "within-person variation in alcohol exposure") can lead to misclassification of individuals, which in turn can distort the true nature of the risk-relationship between "usual" alcohol exposure and CHD risk. Moreover, without knowing the nature of the misclassification (ie, whether it is random or systematic), one cannot predict whether the apparent "baseline" risk-relationship underestimates, overestimates, or even reverses the direction of the "true" risk-relationship. Nonetheless, many studies have reported associations between CHD risk and single measures of alcohol intake ascertained five, ten, or even twenty years earlier, with little, if any, discussion of the potential effect that within-person variation in alcohol exposure might have. However, by asking people about their alcohol intake at one or more follow-up assessments during a study, the nature and magnitude of this variation may be estimated and its effects explored. Several studies have either directly or indirectly assessed the effects of within-person variation in alcohol exposure in this way. In the British Doctors\' Study, it was concluded that because a reasonable degree of consistency between alcohol intake at the beginning and end of the study was observed, their results would have been quite robust to the effects of within-person variation ([@b11]). Of the studies that have attempted to directly take account of within-person variation in alcohol exposure, most have used just two assessments of alcohol intake, and findings have been inconsistent ([@b15]; [@b74]). For example, in the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)-Augsburg cohort, it was found that the estimated benefits of light alcohol consumption increased after taking the second measure of alcohol consumption into account ([@b74]), while in the First National Health and Nutrition Examination Survey, no elevated mortality was observed when consistent never drinkers were compared with light drinkers ([@b15]). In the Health Professionals Follow-up Study, assessment of alcohol intake every 4 years allowed examination of the effects of changes in alcohol consumption on the 12-year risk of myocardial infarction (MI). In this large American study, the beneficial effects of alcohol consumption on the risk of MI estimated using baseline measurements were found to be similar to estimates derived from analyses that fitted alcohol consumption as a "time-dependent" covariate ([@b42]). However, three other large American studies have demonstrated that baseline measures of drinking groups may be particularly unreliable for younger samples, longer follow-up, and heavier drinkers ([@b30]). Recently, an analysis of the British Regional Heart Study demonstrated that by taking into account information on alcohol intake obtained after 5, 13, 17, and 20 years of follow-up (in addition to the information obtained at baseline), individuals could be categorized into exposure groups that were much better at predicting 20-year CHD risk than groups defined only from baseline information ([@b12]). When compared with occasional drinking (defined as 1--2 times a month or on special occasions), the relative risk of CHD associated with heavy drinking increased from 1.08 (95% CI 0.86 to 1.35) to 1.44 (95% CI 1.21 to 1.72) when repeat information on alcohol intake was taken into account. This suggests that studies that relate CHD rates to single assessments of alcohol intake recorded many years earlier may systematically underestimate true risks associated with heavy drinking.

Confounding
-----------

We now come to a common problem that arises when interpreting any epidemiological study -- the possibility for associations to be distorted because of confounding. Specifically, characteristics that are related both to alcohol consumption and to CHD risk have the potential to modify both the shape and magnitude of the true alcohol--CHD relationship. For instance, it is well recognized that regular light drinkers tend to exhibit a range of socioeconomic, behavioral, and physical characteristics which are advantageous to health. This was confirmed in a recent telephone survey of 200 000 adults in the US, in which 27 out of 30 cardiovascular risk factors were found to be significantly more prevalent among nondrinkers than light-to-moderate drinkers ([@b45]). Observational studies attempt to take this into account by adjusting for these characteristics in statistical analyses. In the INTERHEART study of about 15 000 cases of MI and 15 000 controls from 52 countries, regular alcohol use (defined as 3 or more times per week) was associated with a 21% (95% CI 14% to 27%) reduction in MI risk after adjustment for age, sex and smoking, but only a 9% reduction after further adjustment for other coronary risk factors, though it should be recognised that this included factors likely to mediate the alcohol--MI relationship, eg, blood lipids ([@b77]). Simple adjustment for measured levels of confounders may not remove all of the effects of confounding however. This is because confounders are typically measured only crudely, eg, cigarette smoking exposure may be recorded as current, ex, or never rather than in a more detailed manner that included type of cigarette smoked and pack-years smoked. Thus, even after "adjustment" for these characteristics, some of the remaining coronary benefit associated with light-to-moderate drinking in epidemiological studies may still be due to confounding (referred to as "residual confounding"). Nonetheless, it has been argued that the degree of consistency in the alcohol--CHD relationship that is observed across diverse populations reduces the likelihood that the benefits of light-to-moderate amounts of alcohol can be due entirely to confounding, leaving causality as the only remaining plausible explanation ([@b37]; [@b36]). Residual confounding among heavy drinkers also has the potential to explain some (perhaps all) of the coronary hazard associated with heavy drinking (since heavy drinkers tend to possess several harmful characteristics). The potential for this "bi-directional" confounding to occur (ie, confounding as a possible explanation both for the protective effect of alcohol among light drinkers *and* the harmful effect of alcohol among heavy drinkers), has led some to suggest that the coronary-protective effects of alcohol might actually only become apparent at moderate-to-heavy levels of drinking, and not light levels of drinking at all ([@b26]). Of course, any possible benefits on coronary risk from moderate-to-heavy levels of drinking would be greatly outweighed by increases in non-vascular risks ([@b6]).

Study design and biases in the literature
-----------------------------------------

Studies of the effect of alcohol on CHD risk tend to be either prospective cohort studies or case-control studies (though occasionally nested case-control designs are also used). Cohort studies have the intrinsic advantage over case-control studies that they should be less prone to reverse causality bias, since assessments of alcohol exposure are typically made before the onset of CHD. Case-control studies (though usually much more efficient than cohort studies in terms of time, money and effort) have the additional problems of finding an appropriately matched control group and ensuring that no recall biases in alcohol consumption are introduced ([@b57]). In particular, any differential biases in the recall of alcohol consumption between cases and controls could be especially problematic, having important implications for the estimation of risk-associations. In a meta-analysis of studies of the relationship between alcohol and CHD published between 1966 and 1998, significant differences were observed between the findings of cohort and case-control studies. Cohort studies typically observed lower protective effects of moderate alcohol consumption ([@b7]). Another obstacle facing researchers who wish to provide an overview of the effects of alcohol on CHD risk is that there may be substantial publication bias in the literature. This became evident in the meta-analysis carried out by [@b7]. Small studies reporting adverse effects of moderate drinking were found to be less likely to be published than small studies reporting beneficial (or no) effects of moderate alcohol consumption on CHD risk ([@b7]). Finally, there may also be an intrinsic bias in the literature caused by the tendency of some authors to present and interpret their results in a way that best confirms their prior beliefs, though the effect of this potential source of bias is of course much more difficult to quantify.

Alcohol intake and stroke
=========================

Alcohol was first recognized as a possible risk factor for stroke in 1725. More recently, many epidemiological studies have studied the association between alcohol and stroke, generally finding, as for CHD, that light to moderate drinkers have a lower risk than abstainers, and heavy drinkers have increased risks. In a meta-analysis of 35 observational studies published between 1966 and 2002, which combined the results from 16 case-control and 19 prospective studies, drinking up to 12 g of alcohol a day was associated with a 17% (95% CI 9% to 35%) reduction in the risk of total stroke (compared with nondrinking), while drinking more than 60 g of alcohol a day was associated with a 64% (95% CI 39% to 93%) increase in the risk of stroke ([@b51]).

To what extent might these associations be causally attributed to alcohol consumption? Many of the issues already discussed regarding the potential sources of bias in alcohol--CHD risk relationships apply equally for alcohol--stroke risk relationships. Thus, the apparent benefit of light-to-moderate drinking on total stroke risk observed in most populations could be due to residual confounding, contamination of the non-drinking group by ex-drinkers, or failure to take account of within-person variation in alcohol intake. In the British Regional Heart Study, for instance, taking within-person variation into account removed the apparent excess stroke risk experienced by nondrinkers (compared with occasional drinkers), and increased the relative risk of stroke for heavy drinkers relative to occasional drinkers from 1.54 (95% CI 1.06 to 2.22) to 2.33 (95% CI 1.46 to 3.71) ([@b12]). In another study of ∼20 000 middle-aged Japanese men followed for 11 years (the Japan Public Health Center \[JPHC\] Study Cohort I \[[@b25]\]), occasional and light drinkers (defined as \<21 g/day) had the highest proportion of nonsmokers, the highest proportion of people who exercised at least once a week and the highest frequency of fruit intake, whereas people who drank at least 64 g of ethanol a day had the lowest proportions of each of these characteristics. Using occasional drinkers as the reference category, and taking differences in these confounders into account (as well as differences in BMI, education level, and history of diabetes) the risk of any stroke was found to increase linearly with alcohol intake to a relative risk of 1.55 (95% CI 1.11 to 2.15) amongst the heavy drinkers. These results were comparatively unaffected by "updating" alcohol intake using repeated information collected in 90% of people still alive after 5 years of follow-up.

Stroke sub-type and alcohol
---------------------------

In the JPHC study, stroke risk increased linearly with alcohol intake, apparently contradicting the U-shaped relationship observed in most cohort studies. However, if ischemic and hemorrhagic strokes are considered separately, the reason for this apparent discrepancy becomes evident. In most Western countries, approximately 70% to 80% of strokes occurring in middle-age are ischemic. Thus, the relationship between alcohol and total stroke in these populations generally reflects that observed with ischemic stroke. In the Physicians\' Health Study, for instance, light and moderate drinking (1 drink/week and 2--4 drinks/week respectively) were found to be associated with reduced risks of ischemic stroke (relative risk \[RR\]=0.73 \[0.52--1.00\] and 0.74 \[0.56--0.98\] respectively), after adjustment for other stroke risk factors and compared with individuals who drank \<1 drink/week, that were similar to those observed for all stroke ([@b2]). However, for hemorrhagic stroke, no significant association (in either direction) with alcohol intake was observed. Similarly, in the Nurses\' Health Study of ∼87 000 female nurses, a decreased risk of ischemic stroke among those drinking moderate amounts of alcohol (1.5 g to 14.9 g per day) was observed ([@b59]), but hemorrhagic stroke tended to be more common among this group than among the nondrinkers. In the JPHC study however, only around half of the strokes were ischemic. Separating strokes according to etiology, light-drinkers (\<21 g per day) were found to have a reduced rate of ischemic stroke (RR=0.61 \[0.39--0.97\]) consistent with that observed in the American studies, while hemorrhagic stroke displayed a strong log-linear relationship with alcohol intake (RR=2.51 \[1.43--4.41\] for men who drank \>64 g a day compared with occasional drinkers) ([@b25]). Thus, the overall relationship between alcohol intake and stroke in the JPHC study was much more influenced by hemorrhagic stroke than is the case in most other studied populations. In a 2003 meta-analysis of alcohol and stroke ([@b51]), 15 studies contained information on ischemic stroke and 12 contained information on hemorrhagic stroke. In these studies, people who drank less than 12 g of alcohol a day (equivalent to less than 1 drink per day) had the lowest risk of ischemic stroke (RR=0.80, 95% CI 0.75 to 0.91, compared with nondrinkers), while those who drank greater than or equal to 60 g a day had a RR of 1.69 (1.34--2.15). For hemorrhagic stroke however, a linear dose-response association was observed among people who drank any alcohol, with individuals who drank at least 60 g/day having a RR of 2.18 (95% CI 1.48 to 3.20) compared with nondrinkers. Subsequently, in another meta-analysis of observational studies looking at several different causes of mortality including ischemic and hemorrhagic stroke, a non-statistically significant protective effect for ischemic stroke for alcohol intake of 25 g/day was observed when compared with nondrinkers. For hemorrhagic stroke, alcohol consumption of 25 g/day, 50 g/day, and 100 g/day was associated with RRs of 1.19 (0.97--1.49), 1.82 (1.46--2.28), and 4.70 (3.35--6.59) respectively, when compared with nondrinking. Again, the consistency in riskrelationships observed across different study designs in different populations strongly indicates that these alcohol--stroke relationships are, to some degree at least, causal. The question is, how?

Biological mechanisms
=====================

While there is an abundance of evidence to suggest that light-to-moderate alcohol intake protects against CHD as well as ischemic (but not hemorrhagic) stroke, evidence concerning the mechanisms by which these benefits are achieved has historically been more limited. General opinion now however agrees that alcohol consumption is likely to influence the risk of vascular disease primarily through beneficial effects on lipids and fibrinolytic activity ([@b54]), the effects of which are probably offset to some degree by adverse effects on blood pressure ([@b38]).

Effect of alcohol on lipids and hemostatic factors
--------------------------------------------------

It is often stated that between 40% and 60% of the beneficial effect of light-to-moderate alcohol consumption on the risk of CHD is mediated through increases in HDL-C alone ([@b32]; [@b61]; [@b20]; [@b39]), with further benefits achieved through improvements in fibrinogen level and other clotting factors ([@b54]). In a case-control study of 340 patients with MI, for instance, the log relative risk of MI associated with drinking more than 3 drinks a day compared with drinking less than 1 drink a month was attenuated by 60% after adjustment solely for the levels of the HDL2 and HDL3 subfractions ([@b20]). In the Nurses\' Health Study and the Health Professionals Follow-up Study, nested case-control studies of alcohol and MI risk showed that at least 75% (higher in men) of the benefit associated with frequent drinking (defined as at least 3 to 4 days per week) and MI risk could be explained by advantageous levels of HDL-C, fibrinogen and hemoglobin A1c among the frequent drinkers ([@b43]). Large population-based studies have confirmed alcohol consumption to be related to beneficial levels of HDL-C and fibrinogen ([@b70]; [@b56]), while genetic association studies of the alcohol dehydrogenase type 3 (ADH3) polymorphism further support a causal effect of alcohol on CHD risk that is mediated by HDL-C ([@b23]; [@b8]). In a meta-analysis of experimental studies investigating the effects of alcohol consumption on blood lipids and haemostatic factors in people with no prior history of chronic disease and no history of alcohol dependence, 30 g of ethanol per day was estimated to increase HDL-C by 3.99 mg/dL, increase apolipoprotein A~1~ by 8.82 mg/dL and decrease fibrinogen by 7.5 mg/dL, but also to increase triglycerides of 5.69 mg/dL. The authors predicted that through its effects on these four biological markers, 30 g of ethanol a day would be expected (from epidemiological studies) to reduce the risk of CHD by 25% ([@b54]). The effect of moderate alcohol consumption on HDL-C would also be expected to lead to a reduction in ischemic, but not hemorrhagic, stroke. However, the anticoagulant effects of alcohol, though beneficial for ischemic stroke, may play an important role in increasing the risk of hemorrhagic stroke.

Effect of alcohol on blood pressure
-----------------------------------

Though alcohol has some favorable effects on blood lipids and hemostatic factors, it also increases blood pressure, one of the most important determinants of cardiovascular disease risk ([@b47]). In 1994, the International Study of Electrolyte Excretion and Blood Pressure (INTERSALT), a study designed to investigate the relations between salt and blood pressure in 50 centres worldwide, presented data on alcohol and blood pressure ([@b38]). As well as ascertaining whether the total amount of alcohol consumed was related to blood pressure, the study investigated whether different patterns of alcohol consumption might have differential influences on blood pressure level. Results showed that heavy alcohol intake (≥300 ml/week \[34 g/day\]) was related to both higher systolic blood pressure (SBP) and higher diastolic blood pressure (DBP) levels: in men, mean blood pressure (SBP/DBP) was 2.7/1.6 mm Hg higher among heavy drinkers than among nondrinkers; this figure was 3.9/3.1 mm Hg in women. Furthermore, differences in blood pressure between drinkers and nondrinkers were found to be greater among "episodic drinkers" (people with the highest daily variation in alcohol consumption) than among people who drank a regular amount of alcohol each day. Similar adverse effects of binge drinking on blood pressure level (independent of amount of alcohol consumed) have also been observed elsewhere ([@b60]). In a recent meta-analysis of epidemiological studies which looked at the association of alcohol consumption with the risk of 15 diseases, alcohol at doses of 25 g/day, 50 g/day, and 100 g/day were associated with relative risks of hypertension of 1.43 (95% CI 1.33--1.53), 2.04 (1.77--2.35) and 4.15 (3.13--5.52) respectively (when compared with individuals who did not drink alcohol) ([@b6]). In another meta-analysis of randomized controlled trials of alcohol reduction, reducing alcohol intake by an average of 67% (from 3--6 drinks per day to 1--2 drinks per day) reduced SBP by 3.3 mm Hg and DBP by 2.0 mm Hg ([@b76]). Though relatively small, long-term differences in blood pressure of this magnitude can have important effects on the risk of CHD and, particularly, stroke. Using estimates of the relations between usual blood pressure and the risk of CHD and stroke mortality from the Prospective Studies Collaboration of one million individuals from 61 prospective studies, it can be calculated that during middle-age (40--59 years) a difference in SBP of 3.3mm Hg is associated with an approximate 12% higher risk of fatal CHD and 19% higher risk of fatal stroke (similar for both ischemic and hemorrhagic), while a 2.0 mm Hg higher DBP level is associated with a 16% higher risk of fatal CHD and 23% higher risk of fatal stroke ([@b47]).

Summary
=======

The consistency of the relationship between light-to-moderate alcohol intake and reduced risks of CHD, together with the existence of plausible biological mechanisms, strongly suggests that moderate alcohol consumption does reduce CHD risk. However, the true magnitude of benefit at any given level may be lower than suggested by most observational studies (mainly because of the difficulties in removing confounding from comparisons as well as the problems caused by the use of nondrinkers as the reference group). Drinking pattern (specifically, drinking with meals) may also have as much influence on reducing CHD risk as overall alcohol amount, though there is little reliable evidence to indicate that any particular type of drink is more or less beneficial than any other. Heavy drinking is associated with increased CHD risk, but the degree that this may be causal is uncertain because while previous studies may have systematically underestimated the risks by not taking within-person variation into account, the observed hazards could also be due to residual confounding. For stroke, the observed relationship between alcohol consumption and risk in a given population depends on the proportion of strokes that are hemorrhagic. Light-to-moderate alcohol intake is associated with a lower risk of ischemic stroke which is likely to be, in part, causal. Hemorrhagic stroke, on the other hand, displays a loglinear relationship with alcohol intake.

In conclusion, drinking 20 g to 30 g of alcohol a day probably reduces major vascular risk in middle-aged people by up to one fifth. However, given that alcohol intake displays clear positive relationships with total mortality in younger people (as well as positive relationships with nonvascular causes of death in middle-aged people), considerable caution in making any general statements about safe levels of alcohol consumption is needed. In particular, any policy that resulted in an overall increase in population average alcohol consumption would be likely to do substantially more harm than good.
